Robust in vivo transduction of nervous system and neural stem cells by early gestational intra amniotic gene transfer using lentiviral vector

Molecular Therapy

Volumn 18, Issue 9, 2010, Pages 1615-1623

  Stitelman, David H ^a,b   Endo, Masayuki ^a   Bora, Archana ^a   Muvarak, Nidal ^a   Zoltick, Philip W ^a   Flake, Alan W ^a,b   Brazelton, Timothy R ^a,b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR;

AMNION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO DEVELOPMENT; FETUS; FETUS DEVELOPMENT; GESTATION PERIOD; IN VIVO GENE TRANSFER; LIFESPAN; MOUSE; NERVOUS SYSTEM; NEURAL STEM CELL; NONHUMAN; SUBVENTRICULAR ZONE; VIRAL GENE DELIVERY SYSTEM;

MURINAE; MUS;

EID: 77956268764     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2010.125     Document Type: Article

References (35)

1. Abrous, DN, Koehl, M and Le Moal, M (2005). Adult neurogenesis: from precursors to network and physiology. Physiol Rev 85: 523-569.
2. Alvarez-Buylla, A, Garca-Verdugo, JM and Tramontin, AD (2001). A unified hypothesis on the lineage of neural stem cells. Nat Rev Neurosci 2: 287-293.
3. Gage, FH (2000). Mammalian neural stem cells. Science 287: 1433-1438.
4. Consiglio, A, Gritti, A, Dolcetta, D, Follenzi, A, Bordignon, C, Gage, FH et al. (2004). Robust in vivo gene transfer into adult mammalian neural stem cells by lentiviral vectors. Proc Natl Acad Sci USA 101: 14835-14840.
5. Gaiano, N, Kohtz, JD, Turnbull, DH and Fishell, G (1999). A method for rapid gain-of-function studies in the mouse embryonic nervous system. Nat Neurosci 2: 812-819.
6. Sena-Esteves, M, Tebbets, JC, Steffens, S, Crombleholme, T and Flake, AW (2004). Optimized large-scale production of high titer lentivirus vector pseudotypes. J Virol Methods 122: 131-139.
7. Naka, H, Nakamura, S, Shimazaki, T and Okano, H (2008). Requirement for COUP-TFI and II in the temporal specification of neural stem cells in CNS development. Nat Neurosci 11: 1014-1023.
8. Endo, M, Zoltick, PW, Chung, DC, Bennett, J, Radu, A, Muvarak, N et al. (2007). Gene transfer to ocular stem cells by early gestational intraamniotic injection of lentiviral vector. Mol Ther 15: 579-587.
9. Endo, M, Zoltick, PW, Peranteau, WH, Radu, A, Muvarak, N, Ito, M et al. (2008). Efficient in vivo targeting of epidermal stem cells by early gestational intraamniotic injection of lentiviral vector driven by the keratin 5 promoter. Mol Ther 16: 131-137.
10. Endo, M, Henriques-Coelho, T, Zoltick, PW, Stitelman, DH, Peranteau, WH, Radu, A et al. (2010). The developmental stage determines the distribution and duration of gene expression after early intra-amniotic gene transfer using lentiviral vectors. Gene Ther 17: 61-71.
11. Coles-Takabe, BL, Brain, I, Purpura, KA, Karpowicz, P, Zandstra, PW, Morshead, CM et al. (2008). Dont look: growing clonal versus nonclonal neural stem cell colonies. Stem Cells 26: 2938-2944.
12. Merianos, D, Heaton, T and Flake, AW (2008). In utero hematopoietic stem cell transplantation: progress toward clinical application. Biol Blood Marrow Transplant 14: 729-740.
13. Hayashi, S, Peranteau, WH, Shaaban, AF and Flake, AW (2002). Complete allogeneic hematopoietic chimerism achieved by a combined strategy of in utero hematopoietic stem cell transplantation and postnatal donor lymphocyte infusion. Blood 100: 804-812.
14. Waddington, SN, Nivsarkar, MS, Mistry, AR, Buckley, SM, Kemball-Cook, G, Mosley, KL et al. (2004). Permanent phenotypic correction of hemophilia B in immunocompetent mice by prenatal gene therapy. Blood 104: 2714-2721.
15. Zhang, CC and Lodish, HF (2004). Insulin-like growth factor 2 expressed in a novel fetal liver cell population is a growth factor for hematopoietic stem cells. Blood 103: 2513-2521.
16. Peranteau, WH, Endo, M, Adibe, OO and Flake, AW (2007). Evidence for an immune barrier after in utero hematopoietic-cell transplantation. Blood 109: 1331-1333.
17. Merianos, DJ, Tiblad, E, Santore, MT, Todorow, CA, Laje, P, Endo, M et al. (2009). Maternal alloantibodies induce a postnatal immune response that limits engraftment following in utero hematopoietic cell transplantation in mice. J Clin Invest 119: 2590-2600.
18. Wehner, T, Böntert, M, Eyũpoglu, I, Prass, K, Prinz, M, Klett, FF et al. (2003). Bone marrow-derived cells expressing green fluorescent protein under the control of the glial fibrillary acidic protein promoter do not differentiate into astrocytes in vitro and in vivo. J Neurosci 23: 5004-5011.
19. Nolte, C, Matyash, M, Pivneva, T, Schipke, CG, Ohlemeyer, C, Hanisch, UK et al. (2001). GFAP promoter-controlled EGFP-expressing transgenic mice: a tool to visualize astrocytes and astrogliosis in living brain tissue. Glia 33: 72-86.
20. Jakobsson, J, Ericson, C, Jansson, M, Björk, E and Lundberg, C (2003). Targeted transgene expression in rat brain using lentiviral vectors. J Neurosci Res 73: 876-885.
21. Sims, K, Ahmed, Z, Gonzalez, AM, Read, ML, Cooper-Charles, L, Berry, M et al. (2008). Targeting adenoviral transgene expression to neurons. Mol Cell Neurosci 39: 411-417.
22. Smith, JD, Sikes, J and Levin, JA (1998). Human apolipoprotein E allele-specific brain expressing transgenic mice. Neurobiol Aging 19: 407-413.
23. Su, M, Hu, H, Lee, Y, dAzzo, A, Messing, A and Brenner, M (2004). Expression specificity of GFAP transgenes. Neurochem Res 29: 2075-2093.
24. Casper, KB and McCarthy, KD (2006). GFAP-positive progenitor cells produce neurons and oligodendrocytes throughout the CNS. Mol Cell Neurosci 31: 676-684.
25. Glover, CP, Bienemann, AS, Hopton, M, Harding, TC, Kew, JN and Uney, JB (2003). Long-term transgene expression can be mediated in the brain by adenoviral vectors when powerful neuron-specific promoters are used. J Gene Med 5: 554-559.
26. Glover, CP, Bienemann, AS, Heywood, DJ, Cosgrave, AS and Uney, JB (2002). Adenoviral-mediated, high-level, cell-specific transgene expression: a SYN1-WPRE cassette mediates increased transgene expression with no loss of neuron specificity. Mol Ther 5(5 Pt 1): 509-516.
27. Baskar, JF, Smith, PP, Nilaver, G, Jupp, RA, Hoffmann, S, Peffer, NJ et al. (1996). The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic mice. J Virol 70: 3207-3214.
28. Encinas, JM and Enikolopov, G (2008). Identifying and quantitating neural stem and progenitor cells in the adult brain. Methods Cell Biol 85: 243-272.
29. Chojnacki, AK, Mak, GK and Weiss, S (2009). Identity crisis for adult periventricular neural stem cells: subventricular zone astrocytes, ependymal cells or both- Nat Rev Neurosci 10: 153-163.
30. Lendahl, U, Zimmerman, LB and McKay, RD (1990). CNS stem cells express a new class of intermediate filament protein. Cell 60: 585-595.
31. Gilyarov, AV (2008). Nestin in central nervous system cells. Neurosci Behav Physiol 38: 165-169.
32. Morshead, CM and van der Kooy, D (2004). Disguising adult neural stem cells. Curr Opin Neurobiol 14: 125-131.
33. Miyoshi, H, Blömer, U, Takahashi, M, Gage, FH and Verma, IM (1998). Development of a self-inactivating lentivirus vector. J Virol 72: 8150-8157.
34. Stanley, MW, Tani, EM and Skoog, L (1989). Metaplastic carcinoma of the breast: fine-needle aspiration cytology of seven cases. Diagn Cytopathol 5: 22-28.
35. Shimokawa, I, Higami, Y, Horiuchi, S, Iwasaki, M and Ikeda, T (1998). Advanced glycosylation end products in adrenal lipofuscin. J Gerontol A Biol Sci Med Sci 53: B49-B51.